Spear Bio
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Sylvan Rd Ste 510, Woburn, Massachus...Phone Number
(781) 937-5245Website
spear.bioRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Spear Bio
Spear Bio founded in 2021 by former Harvard researchers Feng Xuan and Peng Yin, is headquartered in Woburn, MA. The company is devoted to the next generation of ultrasensitive immunoassay technology and collaborates closely with academic researchers, clinicians, and industry to develop more ultrasensitive detection methods and more versatile assay approaches to support non-invasive sample collection methods and cutting-edge laboratory diagnostics.Explore more
Spear Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spear Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Spear Bio had a recent Job posting/layoffs
Product Launch: Get notified when Spear Bio launches new products
Earning: See what the market has to say on Spear Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Spear Bio
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Spear Bio has new funding data
Spear Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Spear Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Spear Bio is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Spear Bio
Compare insights from companies similar to Spear Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spear Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spear Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spear Bio.
Spear Bio financials insights
Gather financial insights about Spear Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$4M
2024
Series A
$45M
Spear Bio Tech Stack
A closer look at the technologies used by Spear Bio
Most Recent Scoops
Hiring Plans
Spear Bio has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: HubSpot, and Salesforce. Areas of expertise include: Sales Process Engineering, and Lead Management.
Hiring Plans
Project
, according to a high-level source in human resources, is in the midst of initiatives related to employee training.
Training, Employee Relations
Project
, according to a high-level source in human resources, is in the midst of initiatives related to FLSA.
Compensation & Benefits, Employee Relations, Labor & Employment Policy
Project
, according to a high-level source in human resources, is in the midst of initiatives related to audits.
Audit, Internal Audit & Control, Finance
Project
Workforce Management, HR Operations, Organizational Development
Spear Bio News & Media
Bio-Techne to distribute Spear Bio's ultrasensitive immunoassays - Medical Device Network
Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
WOBURN, Mass.--(BUSINESS WIRE)--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, focusing initially onBio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
MINNEAPOLIS, July 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne...Spear Bio Secures FDA Breakthrough Device Designation for its Novel pTau 217 Blood Test, Advancing Scalable Solutions for Early Alzheimer's Disease Diagnosis
WOBURN, Mass., Jan. 13, 2025 /PRNewswire/ -- Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spear Bio
Sign Up For FreeTo access detailed company insights
Spear Bio founded in 2021 by former Harvard researchers Feng Xuan and Peng Yin, is headquartered in Woburn, MA. The company is devoted to the next generation of ultrasensitive immunoassay technology and collaborates closely with academic researchers, clinicians, and industry to develop more ultrasensitive detection methods and more versatile assay... Read More
